- Aspen Dental targets fast-growing Georgia city for new practice
- Michael Dowling: Now is not the time to abandon gun safety efforts
- A new wording test on ‘Medicare for All’
- UCI Health started as 1 hospital. 50 years and 6 hospitals later, CEO charts its future
- Virtua Health names president of 2 New Jersey hospitals
- Colorado wildfires send dozens to UCHealth hospitals
- Northwell appoints chair of surgery
- How 5 health systems are avoiding a repeat of the 2023 chemo shortage
- Nashville General taps CEO
- NewYork-Presbyterian rolls out OpenEvidence AI across its network
- Oswego Health expands surgery, orthopedic services New York
- Vanderbilt professor elected 40th president of bariatric group
- The ASC tax squeeze is gaining momentum
- The private equity race regulators haven’t caught up to
- Weill Cornell taps new chair of surgery, surgeon-in-chief
- The state-by-state battle over anesthesia time caps
- What happens to ASC contracts when a payer gets absorbed
- What will make or break the future of DSO success
- Dentistry reaches inflection point with AI
- Former UPMC cardiologist drops lawsuit over CEO’s device company ties
- Dental assistant pay vs. cost of living by state
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- GI consolidation’s new era: 5 deals to know
- The GI procedure cuts in CMS’ pay proposal: 5 things to know
- ‘The economics just don’t work’: CMS’ ACCESS model draws scrutiny
- Washington restricts spit hood use in state psychiatric facilities
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- Maryland health system receives $10M gift to construct ASC
- 1-800-Dentist faces class-action lawsuit over data breach
- Staten Island hospital debuts mobile behavioral health program for youth
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Telehealth ex-CEO sentenced in Adderall fraud case: 5 things to know
- Oklahoma awards 4 behavioral health clinic contracts
- The key to patient trust in dentistry
- Good news, bad news for the dental workforce
- 7 behavioral health layoffs to know | 2026
- 200+ dentists making headlines halfway through 2026
- How students are paying for dental school
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- U of Kentucky dental dean receives top educator award
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- 36 behavioral health executive moves to know
- Delaware establishes statewide opioid treatment guidance for EDs
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- ACA plans set for another year of premium spikes, preliminary filings show
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Foreign drugmaker caught faking doctors’ petition to evade China’s price cut scheme
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Keenova gets on the good foot with Xiaflex trial win in rare tissue growth condition
- Evonik plugs $100M into Indiana drug substance plant as US CDMO demand mounts
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Primary care’s AI moment
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO
- Catalent sells UK facility to Codis, expands Nanoscope partnership
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Nonprofit-private equity joint ventures worth scrutiny, PESP report says
- American Heart Association joins social network Roon for medical research collaboration
- Independent pharmacies hit Prime Therapeutics with antitrust suit over alleged price fixing
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Novartis dismisses 322 more staffers based out of US headquarters
- Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa
- FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka
- Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B
- Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub
- Skin quality driving widespread quality-of-life issues: survey
- AI care partner Heidi puts a spin on pharma ad tropes in new campaign to relieve 'side effects'
- Nonprofit hospitals are embracing high-risk, high-reward investment portfolios. Is that a problem?
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Teladoc Health inks multi-year virtual care deal with National Basketball Players Association
- FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- New Medicaid Work Rule Means More Opportunities To Lose Coverage
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Epic plans to expand 4 executives' roles as President Sumit Rana exits the company
- Journalists Discuss Healthcare Costs’ Political Fallout, Concerns About Canceled ICE Facility
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- He Dreamed Of Becoming A Physician Assistant. New Loan Rules May Thwart Him.
- HealthQ Special: Caregiving in the Sandwich Generation
- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Closed the File.
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Regulatory tracker: AbbVie, Genmab's blood cancer bispecific expands label in EU
- Can A Popular Muscle Supplement Help Treat Depression?
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
Michigan healthcare freedom community forum
This is how you get your Cabinet nominees confirmed, double quick time, without histrionics. The Democrats stalling RFK, Jr. just ran out of slack. From Gizmodo, a mouthpiece of the left:
https://gizmodo.com/trump-orders-cdc-fda-and-other-health-agencies-to-go-dark-2000553437
Trump Orders CDC, FDA, and Other Health Agencies to Go Dark
The communications pause could be an early sign of things to come under a renewed Trump White House.
By Ed Cara | January 22, 2025The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the U.S. Department of Health and Human Services. This week, the returning Trump administration told these agencies to stop talking to the public—for how long, no one knows.
The Washington Post first broke news of Trump’s sweeping directive late Tuesday evening. Staff at these agencies have been reportedly ordered to cease external communication for the time being. The move is the latest to unnerve outside experts about the direction of the country’s public health infrastructure under Trump.
The order was delivered by Stefanie Spear, a newly hired deputy chief of staff at HHS, according to the Post. Spear was the press secretary for Robert F. Kennedy Jr. during his 2024 presidential campaign, who has since been nominated by Trump to lead HHS. Affected staff told the Post that the directive lacked specific details, including the reasoning behind it, how long the pause is expected to last, and whether there are any exceptions allowed.
Gizmodo reached out to the HHS for comment but did not hear back by the time of publication.
It’s certainly possible that the White House is simply trying to make it easier for its new health officials to transition into their roles. And this isn’t an unprecedented action for the White House to take to accomplish that, according to Carmen Marsit, executive associate dean at Emory University’s Rollins School of Public Health.
“It is not uncommon for a new administration to ask for a pause on communications, website updates, etc, in order for new leadership to review the information, understand how information flows, and then work to continue communications,” Marsit told Gizmodo in an email. At the same time, he added, the scope of this directive is currently unknown, as is its potential impact on the public.
Emerging outbreaks, new discoveries, and noteworthy drug approvals are just some of the many things that agencies like the CDC and FDA regularly communicate to the general public and clinicians. Research led by or conducted with the help of government scientists is also routinely published in the CDC’s Morbidity and Mortality Weekly Report (MMWR), which has often served as an early look into important health trends and crises (the first reported cases of what came to be known as HIV/AIDS, for instance). According to the Post, CDC staff were planning to publish several reports in the MMWR this week, including three concerning H5N1—a highly pathogenic strain of avian influenza that has increasingly started to infect cattle, other mammals, and humans since last year.
Halting communication from federal health agencies like the CDC, NIH, and FDA during an administration transition is highly problematic, especially with active public health threats like the H5N1 outbreak in the U.S. and the Marburg outbreak in Tanzania, according to Krutika Kuppalli, an infectious disease physician in Dallas with experience in global health and pandemic preparedness.
“A blanket suspension of external communication from health agencies is unusual and potentially harmful,” Kuppalli told Gizmodo. “Trust in institutions like the CDC is built on transparency and reliability. A lack of communication could lead to skepticism or distrust, making it harder to re-establish credibility when communication resumes.”
There’s also past history to consider, as the Trump-led White House has a track record of muzzling its federal agencies and scientists. In the early days of Trump’s first term, the administration similarly ordered several agencies, including the United States Department of Agriculture, to temporarily stay quiet (much of this directive was quickly revised, however). More worryingly, the Trump administration prevented health officials from communicating with the press and public in the early months of the covid-19 pandemic, while his staff reportedly later tried to alter reports from the CDC concerning covid-19—allegedly with the goal of downplaying the harms of the pandemic.
The potential next leader of HHS, RFK Jr., has also made it clear that he wants to dramatically change the direction of the country’s public health agencies, and likely not for the better. RFK Jr. has regularly espoused false or misleading statements about vaccines and other health-related topics, for instance, and he’s promised to suspend government-led research on infectious diseases if given the chance. And earlier this week, Trump signed an executive order reinstating his plan to have the U.S. leave the World Health Organization, which has played a vital role in supporting public health globally.
“The CDC collaborates with international partners to tackle global health challenges,” noted Kuppalli, who has previously worked with the WHO as a medical officer on covid-19. “The planned withdrawal from WHO already has implications for the U.S.’ role in global health, but a communication freeze could further undermine the U.S.’ reputation as a leader in public health.”
Should this pause linger on, it may be an early indication that the CDC and other agencies will face new challenges from the Trump administration that might prevent them from communicating honestly with the public. And that’s likely to bode very badly for the rest of us.
“While it is the prerogative of any administration to align federal agencies with their vision and goals, public health must remain a nonpartisan priority,” Kuppalli said. “Ensuring continuity of communication from agencies like the CDC, FDA and NIH during transitional periods is not only wise but essential for safeguarding the health and well-being of the public.”
Federal health employee travel has been curtailed. Participation in and sponsorship of external meetings has also been suspended:
US health agencies cancel external meetings, travel after Trump admin directives
By Julie Steenhuysen - January 23, 2025Summary
* 'One Health' bird flu call canceled this week -source
* Travel ban enacted for all health agency employees
* CDC weekly publication of scientific reports did not publish on ThursdayCHICAGO, Jan 23 (Reuters) - U.S. health agencies including the CDC this week canceled meetings with external groups, paused some public health publications and told employees to freeze travel after directives from the Department of Health and Human Services, two sources familiar with the situation said.
On Wednesday, a state/federal call scheduled for Thursday involving states affected by H5N1 bird flu in dairy cattle and other animals was canceled, one of the sources said. It also postponed a training session for public health practitioners, the source said.
The source said the H5N1 bird flu calls occur on a regular schedule, and was aware only that the Thursday session, which was designated a "One Health" call involving both human and animal health issues, was canceled.
Presidential transitions often involve some pause in communications but the source characterized the current scope as broad.
South Dakota's state veterinarian Beth Thompson confirmed that the Centers for Disease Control and Prevention on Wednesday canceled an upcoming, regularly scheduled call with state veterinarians that would normally focus on bird flu. "There was no reason given," she said.
However, the U.S. Department of Agriculture did hold a regularly scheduled call on Wednesday on tracing the location of diseased or at-risk animals through its Veterinary Services program, Thompson said.
Scientists and public health officials are growing increasingly concerned about the spread of H5N1 bird flu, which has infected nearly 70 people in the U.S. since April. Most cases have been mild and occurred in farm workers, according to the CDC.
Earlier this month, however, the United States reported its first death from bird flu after an older person was exposed to a combination of backyard chickens and wild birds.
The cancellations followed a memo from acting HHS Secretary Dorothy Fink seen by Reuters that called for an immediate pause on issuing documents and public communications, including on any speaking engagements until the material has been reviewed and approved by a presidential appointee.
The pause is intended to extend through Feb. 1.
HHS said in a statement that its pause was for public communications not directly related to emergencies or critical to preserving health, and said exceptions for mission critical communications would be made on a case-by-case basis.
A travel ban directive was sent in a Jan. 21 memo to financial officers and travel officials within all operating divisions of HHS, including the National Institutes of Health, the Food and Drug Administration and the CDC, according to an HHS official who was not authorized to speak publicly on the matter.
The travel ban is in effect until further notice, according to the HHS official, who read portions of the memo to Reuters.
It specifies that any speaking engagements that had been accepted prior to Jan. 20 must be canceled.
Travel is only authorized for people who have already departed on an official trip, and the traveler must return to the original point of departure.
Employees from the Indian Health Service are exempted from the suspension.
While a few health communications have been issued since the ban – the FDA on Wednesday put out details of a new safety warning on a drug, for instance – others were canceled.
FIRST PAUSE SINCE 1960
The CDC's Morbidity and Mortality Weekly report, or MMWR, which includes scientific reports from the agency and outside scientists, was not published on Thursday as planned. HHS did not comment on when publication would resume.
In a post on X, former CDC director Dr. Tom Frieden said the MMWR, which is used to inform health officials about emerging threats, had been published weekly without pause since 1960. Delays in its publication put Americans' health at risk, Frieden said.
Dr. Jeremy Faust, a Boston-based emergency physician and author of the Inside Medicine newsletter published on the Substack platform, said the NIH was told to halt the process that approves funding for new scientific and medical research, citing an email shown to him by an NIH official.
The memo noted that all such advisory meetings had been canceled, but noted that such work would be rescheduled.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























